Navigation Links
Insulet Reports First Quarter 2008 Results
Date:5/13/2008

1,200 New Patients Shipped in the Quarter

Production Increases to 95,000 OmniPods per Month

Salesforce Expands to Cover All 50 States

BEDFORD, Mass., May 13 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), a leader in wearable insulin pump technology with its OmniPod(R) Insulin Management System, today announced financial results for the first quarter ended March 31, 2008.

First quarter 2008 reported revenue increased 232% to $6.7 million compared to $2.0 million in the first quarter of 2007. On a sequential basis, reported revenue rose 53% from $4.4 million in the fourth quarter of 2007. During the first three months of 2008, approximately 1,200 new patients began using the OmniPod System.

Reported revenue for the first quarter of 2008 was favorably impacted by $1.2 million due to a change in the Company's estimate of deferred revenue. Prior to the first quarter of 2008, the Company deferred revenue on all initial shipments from the final 45 days in the quarter. The Company's deferred revenue is now based on its two years of historical experience.

Net loss for the first quarter of 2008 was $19.9 million, or $0.73 per share, compared to a net loss of $11.6 million or $23.86 per share for the first quarter of 2007. Total operating expenses increased to $16.7 million in the first quarter of 2008 compared to $8.2 million in the first quarter of 2007 and $13.7 million in the fourth quarter of 2007. Most of the increase in operating expenses was related to higher sales and marketing expenses as the Company's commercial expansion continues.

"We are pleased that we delivered another strong quarter as we continued to launch OmniPod across the United Sta
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
2. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Adaptive Biotechnologies today announced the recent ... The University of Texas MD Anderson Cancer Center ... identification and quantification of populations of B cells ... of people with classical Hodgkin,s lymphoma (CHL). The ... Haematology , represent a first step toward developing ...
(Date:4/28/2015)... ANN ARBOR, Mich. , April 28, 2015 ... OncoTargets and Therapy today shows that the Paradigm ... FoundationOne test across a number of key clinical variables, ... The purpose of the analysis was to ... for profiling cancer patients compared with each other.  ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 More than ... psychosis at some point over the course of their ... symptoms that worsen as the disease progresses. ReachMD ... announces the launch of a series dedicated to PD ... in PD, movement disorders, and psychiatric conditions. , The ...
(Date:4/28/2015)... York, New York (PRWEB) April 28, 2015 ... operations including sales, marketing, and customer service operations across ... The Eeva Test , the first and only FDA-cleared ... proprietary algorithm to aid in embryo selection during IVF. ... career in the field of Reproductive Sciences, including both ...
Breaking Biology Technology:Adaptive Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate Ability to Detect Hodgkin's Lymphoma in Blood 2Adaptive Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate Ability to Detect Hodgkin's Lymphoma in Blood 3Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 2Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 3ReachMD Launches Series Focusing on Parkinson’s Disease Psychosis 2Progyny Appoints Gary Harton as Group Senior Vice President, Commercial Development 2
... Continues to ... Broaden Product Portfolio, WAYNE, Pa., Feb. 14 ... fiscal second quarter and,six months ended December 31, 2007., For ... the Company,s Drew, Vascular and Escalon Digital Solutions (EMI),business units, which ...
... PALO ALTO, Calif., Feb. 14 CV Therapeutics,Inc. ... accordance with Nasdaq,marketplace rule 4350, the Company issued ... due to additional hiring, primarily in,connection with its ... inducement stock options cover an aggregate 119,200 shares ...
... WASHINGTON, Feb. 14 As part of ... create a pathway for,FDA approval of safe and ... features a footprint in the snow stating: "Don,t ... highlights how meaningful biogenerics legislation should be,balanced to ...
Cached Biology Technology:Escalon(R) Reports Second Quarter Fiscal 2008 Results 2Escalon(R) Reports Second Quarter Fiscal 2008 Results 3Escalon(R) Reports Second Quarter Fiscal 2008 Results 4Escalon(R) Reports Second Quarter Fiscal 2008 Results 5Escalon(R) Reports Second Quarter Fiscal 2008 Results 6Escalon(R) Reports Second Quarter Fiscal 2008 Results 7Escalon(R) Reports Second Quarter Fiscal 2008 Results 8CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
(Date:3/26/2015)... , March 26, 2015 ... family, social, recreation and athletic club, today announced it ... to allow freedom of movement for members and staff, ... "Following a comprehensive process, we selected FST,s IMID Access ... and convenience for our members and staff, in addition ...
(Date:3/24/2015)... ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of the ... report to their offering. This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... by a particular enzyme to modify bacterial chromosome chemistry, ... new kind of drug that could stop virulent bacterial ... in the May 6 issue of the journal Cell. ... enzyme called Dam (DNA adenine methyltransferase) plays a role ...
... that can survive encounters with specific immune system cells ... cells, known as neutrophils, dictate whether our immune system ... the research was released today online in The Journal ... Laboratories (RML), part of the National Institute of Allergy ...
... the field of human embryonic stem cell research receives ... also exploring the potential of adult stem cells for ... adult stem cell research isn't fraught with the controversies ... extremely difficult to isolate and then to multiply in ...
Cached Biology News:Scientists take aim at virulent bacteria by decoding machinery of key control enzyme 2Scientists reveal how disease bacterium survives inside immune system cell 2Scientists reveal how disease bacterium survives inside immune system cell 3Researchers discover mechanism for multiplying adult stem cells 2
Request Info...
Secure-Seal™ spacer, one well, 20 mm diameter, 0.12 mm deep *set of 100*...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Biology Products: